Early introduction of tolvaptan after cardiac surgery: a renal sparing strategy in the light of the renal resistive index measured by ultrasound

BACKGROUND: Renal failure is a serious complication after cardiac surgery, which can be caused by long-term intravenous (IV) loop diuretic use. Tolvaptan is an oral selective vasopressin-2 receptor antagonist used in patients irresponsive to loop diuretics. We investigated their renal perfusion chan...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Cardiothorac Surg
Главные авторы: Kato, Tomoko S., Ono, Shunya, Kajimoto, Kan, Kuwaki, Kenji, Yamamoto, Taira, Amano, Atsushi
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4631092/
https://ncbi.nlm.nih.gov/pubmed/26525900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13019-015-0372-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы